Press Release


Jacobson Pharma Launches Smartfish Health Nutrition Products from Norway in Greater China and Asia Pacific Region
Nov 12, 2019 21:05 JST
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaging in research, development, production, marketing and sale of generic drugs and proprietary medicines
More info..

Jacobson Pharma Adds Excilor to Its Portfolio to Develop China Market with Vemedia (The Netherlands)
Nov 05, 2019 23:05 JST
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in research, development, production, marketing and sale of generic drugs and proprietary medicines
More info..

Jacobson Pharma Forms Joint Venture with Kin Fung Weisen-U
Oct 31, 2019 20:25 JST
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaging in the research, development, production, marketing and sale of generic drugs and proprietary medicines
More info..

HKTDC Food Expo opens featuring new Coffee Avenue zone
Aug 15, 2019 19:00 JST
Organised by the Hong Kong Trade Development Council (HKTDC), the HKTDC Food Expo, HKTDC Hong Kong International Tea Fair, HKTDC Beauty & Wellness Expo, HKTDC Home Delights Expo and the International Conference of the Modernization of Chinese Medicine & Health Products (ICMCM) started today at the Hong Kong Convention and Exhibition Centre (HKCEC).
More info..

Jacobson Pharma Announces FY2019 Annual Results
Jun 25, 2019 20:00 JST
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, today announced its annual results of the Company and its subsidiaries (collectively the "Group") for the year ended 31 March 2019 (the "FY2019").
More info..

Jacobson Pharma and Yunnan Baiyao Group to Continue Exploring Further Possibilities of Business Cooperation and Other Collaborations
May 08, 2019 20:15 JST
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaging in the research, development, production, marketing and sale of generic drugs and proprietary medicines, has been informed by Yunnan Baiyao Holdings Company Limited1 ("Baiyao Holdings") and Yunnan Baiyao Group Co.,Ltd.
More info..

Jacobson Pharma Issues Positive Profit Alert
May 02, 2019 22:39 JST
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaging in the research, development, production, marketing and sale of generic drugs and proprietary medicines, has today announced a positive profit alert.
More info..

Jacobson Pharma Announces FY2019 Interim Results
Nov 21, 2018 22:43 JST
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, today announced its unaudited interim results of the Company and its subsidiaries (collectively the "Group") for the six months ended 30 September 2018 (the "reporting period").

More info..

Jacobson Pharma Announces 2018 Annual Results
Jun 25, 2018 20:48 JST
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, today announced its annual results of the Company and its subsidiaries (collectively the "Group") for the year ended 31 March 2018 ("FY2018").

More info..

Jacobson Pharma Updates on TAILORx Study
Jun 13, 2018 23:50 JST
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), the Hong Kong and Macau exclusive distributor of Genomic Health, Inc. (NASDAQ: GHDX), the world's leading provider of genomic-based diagnostic tests
More info..

Jacobson Pharma Ranked No. 1 in "Hong Kong Best Small-Cap Company" in the "Asia's Best Companies Poll 2018" by FinanceAsia
Apr 17, 2018 18:30 JST
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, is pleased to announce that Jacobson Pharma ranked no.1 in the category of Hong Kong Best Small-Cap Company in the "Asia's Best Companies Poll 2018" conducted by FinanceAsia, an authoritative financial magazine in Asia.
More info..

Jacobson Pharma Enters Agreements with Shanghai Henlius Biotech Inc. To Tap Biologics Market
Dec 20, 2017 21:58 JST
Jacobson Pharma Corporation Limited ("Jacobson Group" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines
More info..

Jacobson Pharma Announces FY2018 Interim Results
Nov 22, 2017 22:12 JST
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, today announced its unaudited interim results of the Company and its subsidiaries (collectively the "Group") for the six months ended 30 September 2017 (the "Reporting Period").
More info..

Jacobson Pharma Issues HK$500M Convertible Notes to Dragons 615 Ltd and HH InRe JP, Ltd.
Oct 03, 2017 17:44 JST
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines
More info..

Jacobson Pharma Issues HK$500M of Convertible Notes to Dragons 615 and HH InRe JP, Ltd.
Sep 06, 2017 11:30 JST
Jacobson Pharma Corporation Limited , a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, has proposed to issue Convertible Notes under general mandate, in an aggregate principal amount of HK$500 million due in 2020, to two subscribers namely Dragons 615 Limited and HH InRe JP, Ltd.
More info..

Jacobson Pharma Announces 2017 Annual Results
Jun 25, 2017 09:20 JST
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, has today announced its annual results of the Company and its subsidiaries (collectively the "Group") for the year ended 31 March 2017 ( "FY 2017" ).
More info..

Jacobson Pharma Announces Acquisition of 70% Interest in Hong Ning Hong
Mar 13, 2017 22:19 JST
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production
More info..

Jacobson Pharma to Acquire Saplingtan, Shiling Oil & Col-gan Tablet; Creating an Expandable Proprietary Medicine Platform
Jan 18, 2017 19:44 JST
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, today announced its acquisition of a family of popular household brands, namely, Saplingtan, Shiling Oil and Col-gan Tablet.

More info..

Jacobson Pharma Announces Acquisition of 100% Interest in Ho Chai Kung Brand
Dec 13, 2016 09:17 JST
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary Chinese medicines, today announces the acquisition of 100% interest in a Target Group (comprising "Karen Pharmaceutical Company Limited"
More info..

Jacobson Pharma Announces 2016 Interim Results
Nov 23, 2016 21:27 JST
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development
More info..

Jacobson Pharma Completes Acquisition of Reputable Generic Drug Manufacturer in Hong Kong
Oct 31, 2016 22:00 JST
Jacobson Pharma Corporation Limited today announces the completion of the acquisition of Cawah Holdings Limited ("Cawah Holdings") and its subsidiary namely, Medipharma Limited ("Medipharma") which is a reputable generic drug manufacturer in Hong Kong, at a total consideration of HK$100,000,000.
More info..

Jacobson Pharma Corporation Limited Announces Details of the Proposed Listing on the Main Board of SEHK
Sep 12, 2016 08:46 JST
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"), a leading company engaged in the research, development, production, marketing and sales of and a vertically integrated manufacturer of Generic Drugs ("generics") and Proprietary Chinese Medicines ("PCM") and the largest generic drug company in Hong Kong, has commenced the Hong Kong Public Offering on 8 September 2016 (Thursday), and will end at 12:00 noon on 13 September 2016 (Tuesday).
More info..

Jacobson Pharma Corporation Limited Announces Details of the Proposed Listing on the Main Board of SEHK
Sep 07, 2016 21:10 JST
Jacobson Pharma Corp Ltd, a vertically integrated manufacturer of Generic Drugs and Proprietary Chinese Medicines ("PCM") and the largest generic drug company in Hong Kong, today announced the details for the proposed listing of its shares on the Main Board of the Stock Exchange of Hong Kong Limited ("SEHK").
More info..

Latest Release


More Latest Release >>